When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Wolff-Parkinson-White syndrome

Последний просмотренный: 2 Oct 2025
Last updated: 24 Sep 2024

Резюме

Определение

Анамнез и осмотр

Ключевые диагностические факторы

  • atrioventricular re-entrant tachycardia (AVRT)
Полная информация

Другие диагностические факторы

  • palpitations
  • dizziness
  • shortness of breath
  • chest pain
  • atrial fibrillation
  • atrial flutter
  • congenital cardiac abnormalities
  • sudden cardiac death
  • syncope and presyncope
  • tachycardia in pregnancy
Полная информация

Факторы риска

  • Ebstein anomaly
  • hypertrophic cardiomyopathy
  • mitral valve prolapse
  • atrial septal defect
  • ventricular septal defect
  • transposition of great vessels
  • coarctation of aorta
  • dextrocardia
  • coronary sinus diverticula
  • right and left atrial aneurysms
  • cardiac rhabdomyomas
  • Marfan syndrome
  • Friedreich ataxia
  • family history
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • 12-lead ECG
Полная информация

Исследования, проведение которых нужно рассмотреть

  • echocardiogram
  • treadmill exercise test
  • electrophysiology study
Полная информация

Алгоритм лечения

Начальные

unstable: BP <90/60 mmHg, signs of systemic hypoperfusion or unstable atrial fibrillation

Острый

stable: narrow complex (orthodromic atrioventricular reciprocating) tachycardia

stable: wide complex (antidromic atrioventricular reciprocating) tachycardia

stable: pre-excited tachycardia due to atrial fibrillation or atrial flutter

stable: pre-excited tachycardia due to atrial tachycardia

ПРОДОЛЖЕНИЕ

following acute treatment: asymptomatic

following acute treatment: symptomatic

Составители

Авторы

Hugh Calkins, MD

Professor of Medicine

Director of Electrophysiology

Johns Hopkins University School of Medicine

Baltimore

MD

Раскрытие информации

HC declares that he is a consultant for Medtronic, Biosense Webster, Abbott, and Boston Scientific.

Выражение благодарностей

We would like to acknowledge our cardiology expert panel member, Dr Fred Kusumoto, for his contribution to this topic.

Professor Hugh Calkins would like to gratefully acknowledge Dr David Frankel, Dr Mithilesh K. Das, and Dr Douglas P. Zipes, previous contributors to this topic.

利益声明

DF, MKD, and DPZ declare that they have no competing interests.

同行评议者

Nicolas Palaskas, MD, FACC

Assistant Professor

University of Texas MD Anderson Cancer Center

Houston

TX

利益声明

NP declares that he has no competing interests.

Joseph E. Marine, MD

Associate Professor of Medicine

Director of Electrophysiology

Johns Hopkins University School of Medicine

Baltimore

MD

利益声明

JEM declares that he has no competing interests.

Suneet Mittal, MD

Director

Electrophysiology Laboratory

The St. Luke's-Roosevelt Hospital Center

New York

NY

利益声明

SM declares that he has no competing interests.

Andrew Turley, MB ChB

Cardiology Specialist Registrar

The James Cook University Hospital

Middlesbrough

UK

利益声明

AT declares that he has no competing interests.

Steve Hsu, MD

Associate Professor

Department of Medicine

Division of Cardiology

University of Florida College of Medicine

Jacksonville

FL

利益声明

SH declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.全文  摘要

Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126.全文  摘要

Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016 Apr 5;67(13):e27-115.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Wolff-Parkinson-White syndrome images
  • 鉴别诊断

    • Atriofascicular pathway
    • Lown-Ganong-Levine syndrome
    • Nodofascicular pathway
    更多 鉴别诊断
  • 指南

    • 2023 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation
    • 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
    更多 指南
  • 患者教育信息

    Atrial fibrillation

    更多 患者教育信息
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明